Biotech Business - December 6, 2023
Herantis Pharma raises EUR 4.51 million
Herantis Pharma has carried out an offering of new shares in a directed share issue to institutional and other qualified investors. “We thank our existing shareholders, many of whom participated in this directed issue, for their continued support in developing HER-096 as a promising disease-modifying drug candidate for Parkinson’s disease. We are delighted to welcome […]
Biotech Business - December 4, 2023
EXACT-Tx announces placement of NOK 25 million share issue
EXACT Therapeutics has announced that a private placement has been successfully placed through an allocation of 2,083,333 0ffer shares, at a subscription price of NOK 12 per offer share for total gross proceeds of NOK 25 million. “This financing has been completed without any significant discount to the market price, and we are excited and […]
Clinical Trials - November 29, 2023
Valo Therapeutics receives regulatory approval to expand Phase I trial
Valo Therapeutics received approval from Germany’s PEI (Paul Ehrlich Institute) to extend the tumor types to be treated in the company’s current Phase I trial into two subtypes of sarcoma. “This extension of the study into sarcoma is significant as it broadens the range of patients we can recruit into our PeptiCRAd-1 study. These sub-types […]
Biotech Business - November 24, 2023
Xbrane Biopharma is introducing a cost-savings scheme
Xbrane Biopharma is focusing the company’s development portfolio and, consequently, the development of Xtrudane (biosimilar candidate to Keytruda) has been terminated. Furthermore, a cost-savings scheme is being introduced which is expected to result in around SEK 50 million in annual savings when fully implemented, states the company. The development of Xtrudane has been terminated Xbrane’s […]
Biotech Award - November 20, 2023
BioArctic’s Lecanemab wins two categories at The Scrip Awards
Lecanemab was awarded the Best New Drug and the award for the Clinical Advance of the Year at the Scrip Awards 2023. The Scrip Awards celebrate the best innovations and achievements of the international biopharma industry. The award for Best New Drug recognizes excellence in pharmaceutical development and celebrates lecanemab as the first and only […]
Biotech Business - November 15, 2023
Gedea Biotech raises EUR 1.5 million
Gedea Biotech has raised the financing to initiate and accelerate clinical trial activities supporting pHyph applicable for antibiotic free treatment of vaginal infections. The funds will be used to initiate patient recruitment in the recently approved registration CL3-2-study, reach upcoming data readout from the CL4 -study to obtain pHyph proof-of-concept for treating vaginal fungal infections, […]
